Date: Thursday, November 5, 2020Time: 11am ET / 8am PTDuration: 1 Hour
Through market and patient research, the key enablers for these outcomes include transitioning from intravenous to subcutaneous injections, combination therapies, as well as new device technologies. Together these enablers are leading to new possibilities and improving patient outcomes.